Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1668-84-4 | MDL No. : | MFCD09038121 |
Formula : | C7H7NO2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | KQMXPHISFRKBJP-UHFFFAOYSA-N |
M.W : | 137.14 | Pubchem ID : | 10313165 |
Synonyms : |
|
Num. heavy atoms : | 10 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.14 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 36.91 |
TPSA : | 44.48 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.39 cm/s |
Log Po/w (iLOGP) : | 1.53 |
Log Po/w (XLOGP3) : | 1.05 |
Log Po/w (WLOGP) : | 1.01 |
Log Po/w (MLOGP) : | 0.55 |
Log Po/w (SILICOS-IT) : | 1.24 |
Consensus Log Po/w : | 1.08 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.8 |
Solubility : | 2.19 mg/ml ; 0.016 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.57 |
Solubility : | 3.65 mg/ml ; 0.0266 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -1.76 |
Solubility : | 2.38 mg/ml ; 0.0173 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.12 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
100% | With hydrogenchloride In 1,4-dioxane at 18 - 22℃; for 1 h; | The Boc starting material G2 (257 mg; 1.08 MMOL) was dissolved in 4M HCI/DIOXANE (5.0 mL) and stirred at room temperature for 1 hr. The solvent was evaporated and the residue diluted with saturated sodium bicarbonate (few mL) and 1 M NAOH (1 ML), extracted with EtOAc (2x), dried (MGS04), filtered and evaporated to dryness to provide the crude 2, 3-methylene DIOXYANILINE G3 (158 mg; 106percent). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
63% | With hydrogen In ethanol for 4 h; | [d][1 ,3]dioxol-4-amine To a solution of 4-nitrobenzo[d][1 ,3]dioxoie (2.0 g, 12 mmol) in ethanol (80 mL) was added Raney Ni (ca. 0.5 g). The mixture was stirred under an atmosphere of hydrogen for 4 hours. The catalyst was removed by filtration and the filtrate was concentrated. The residue was purified by silica gel chromatography (dich.oromethane) to afford the product benzo[d][1.3]dioxol-4-amine (1 .04 g, yield 63 percent). H NMR (400 MHz, CDCI3) δ ppm 6.64-6.68 (t, 1 H, J = 8.0 Hz), 6.29-6.35 (dt, 2H, J = 0.8 Hz, 6.4 Hz), 5.90 (s, 2H), 3.52 (br, 2H). |
[ 39547-15-4 ]
2-Amino-5-methoxyphenol hydrochloride
Similarity: 0.77
[ 97174-59-9 ]
1,3-Bis(benzo[d][1,3]dioxol-4-yl)urea
Similarity: 0.75
[ 94158-14-2 ]
2-(Benzo[d][1,3]dioxol-5-ylamino)ethanol hydrochloride
Similarity: 0.75
[ 175136-34-2 ]
3,4-Dihydro-2H-1,5-benzodioxepin-7-amine
Similarity: 0.71
[ 1000802-34-5 ]
6-Iodobenzo[d][1,3]dioxol-5-amine
Similarity: 0.70